Personal20192020202120222023
Personal am Ende des Jahres7.3947.5557.6647.7717.604
Staff turnover in EUR566.097635.389795.736989.020891.549
Turnover LabelEUREUREUREUREUR
Die Aktie: Angaben in EURO20192020202120222023
Aktien im Umlauf (in Mio.)73.016,0073.202,0073.202,001.645,3873.202,00
Dividende pro Aktie140105767840
unverwässertes Ergebnis pro Aktie95,95130,66184,29227,64197,83
GuV in Mio. EURO nach IAS/IFRS20192020202120222023
Umsatz686.184,0786.945,0999.758,01.259.946,01.111.367,0
Operatives Ergebnis (EBIT)1.268,21.818,62.557,53.239,42.697,0
Ergebnis vor Steuer (EBT)207.893,0298.188,0419.385,0531.166,0443.821,0
Annual net profit/ loss157.560,0214.733,0302.995,0374.429,0325.472,0
Bilanz in Mio. EURO nach IAS/IFRS20192020202120222023
Aktiva
Summe Umlaufvermögen699.680,0834.906,01.063.661,01.336.537,01.366.426,0
Summe Anlagevermögen359.235,0400.592,0475.033,0533.221,0566.121,0
Summe Aktiva1.058.915,01.235.498,01.538.694,01.869.758,01.932.547,0
Passiva
Summe kurzfristige Verbindlichkeiten179.268,0236.070,0327.422,0423.730,0288.217,0
Summe langfristige Verbindlichkeiten25.661,019.424,023.255,021.641,018.749,0
Summe Rückstellungen9.442,04.424,05.046,06.067,05.739,0
Summe Eigenkapital853.985,0980.003,01.188.017,01.424.387,01.625.580,0
Summe Passiva1.058.915,01.235.498,01.538.694,01.869.758,01.932.547,0
Management:
Osamu Okuda
Hisafumi Yamada
Junichi Ebihara
Satoko Shisai
Shinji Hidaka
Tetsuya Yamaguchi
Toshiaki Itagaki
Yoshiyuki Yano
Aufsichtsrat:
Christoph Franz
James Sabry
Iwaaki Taniguchi
Mariko Momoi
Masayuki Oku
Motoo Ueno
William Anderson
Yoichiro Ichimaru
Aktionärsstruktur in %:
Adresse: Nihonbashi Mitsui Tower, 15/F, 2-1-1 Nihonbashi-Muromachi, 103-8324 Tokyo
T: +81-3-3281-6611
F: +81-3-3281-6607
I: http://www.chugai-pharm.co.jp
E: